# Sildenafil Citrate Added to Low Molecular Weight Heparin and Low Dose Aspirin in High-risk Pregnancy

> **NCT04110444** · — · WITHDRAWN · sponsor: **Fayoum University Hospital**

## Conditions studied

- High Risk Pregnancy

## Interventions

- **DRUG:** Sildenafil

## Key facts

- **NCT ID:** NCT04110444
- **Lead sponsor:** Fayoum University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-01
- **Primary completion:** 2022-12
- **Final completion:** 2023-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2022-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04110444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04110444, "Sildenafil Citrate Added to Low Molecular Weight Heparin and Low Dose Aspirin in High-risk Pregnancy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04110444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*